Together with an international team, Johannes Karges has developed an active substance that uses ultrasound to unfold its cell-damaging effect only where it is supposed to.
Credit: RUB, Marquard
Platinum complexes are among the most commonly used drugs against cancer. They are successful, but have severe side effects. An international research team led by Dr. Johannes Karges from the Faculty of Chemistry and Biochemistry at Ruhr University Bochum, Germany, has developed a complex that accumulates in tumour tissue and is activated there by ultrasound waves.
Its cell-damaging effect thus only unfolds where it is actually wanted. “Where previous studies relied on light activations that can only penetrate a few millimetres deep into the tissue, we have now developed a treatment method with ultrasound activation that penetrates several centimetres deep into the body,” says Karges. This could make treatment with few side effects possible even for large and deep-seated tumours.
The researchers published their results in the journal Angewandte Chemie International Edition of 24 March 2023.
Harmless in healthy tissue
The platinum(II) complexes cisplatin, oxaliplatin and carboplatin are among the most commonly used cancer drugs. Their clinical success is offset by severe side effects, such as nausea, vomiting, kidney damage and bone marrow suppression. To overcome these limitations, major research efforts have been invested in the development of so-called platinum(IV) complex prodrugs over the past decades. “These prodrugs are stable and inactive, so they are completely harmless,” explains Johannes Karges. “In healthy tissue, they are supposed to stay that way. In cancer tissue, however, they should be rapidly converted into the therapeutically active platinum(II) complexes.”
Energy is required for the reduction of the metal complex. Previous studies reported activation with ultraviolet, blue or red light. “The problem is that light can only penetrate less than a centimetre deep into the body and thus does not reach many tumours,” explains Johannes Karges. To overcome this limitation, his team has for the first time combined platinum(IV) complex prodrugs with sonosensitizers that can be selectively activated with ultrasound irradiation.
Nanoparticles accumulate in the tumour
To develop a therapeutically effective complex, the researchers encapsulated the platinum(IV) complex prodrugs and the sonosensitizers together in haemoglobin to form nanoparticles. “We were able to observe that the nanoparticles selectively accumulated in a mouse intestinal tumour after injection into the bloodstream, thus supporting targeted treatment,” reports Johannes Karges. “After irradiation with ultrasound, the platinum(IV) prodrug was activated at the tumour site, triggering the release of cisplatin, which is toxic to cells, and almost completely eradicating the tumour.”
Advantages of ultrasound
These results could pave the way for the development of novel techniques and agents for the treatment of very large or deep-seated tumours. Ultrasound can penetrate more than an order of magnitude deeper into tissue than near-infrared light. In addition, ultrasound treatments are generally considered to be less invasive and easy to use. Another advantage is that hospitals are usually already equipped with the necessary equipment. “Our work is still fundamental research,” Johannes Karges emphasises. “Whether and when treatments based on this can be offered in clinical practice is not yet foreseeable.”
Original Article: Ultrasound activates anticancer agent
More from: Ruhr University Bochum
The Latest Updates from Bing News
Go deeper with Bing News on:
Ultrasound anticancer agent activation
- Brain Tumor News
Biodegradable Ultrasound Opens the Blood-Brain Barrier ... it can prevent cancer from recurring. ... First Test of Anti-Cancer Agent PAC-1 in Human Clinical Trials Shows Promise Dec. 22, 2022 ...
- Researchers develop novel photo-oxidation therapy for anticancer treatment
The findings offer a new strategy, called photo-oxidation therapy, and provide a promising direction for the development of anti-cancer drugs ... and chemotherapy agents, activate the immune ...
- Anti-cancer agents in medicinal chemistry
Synthesis, Anticancer, and Antibacterial Activity of Betulinic and Betulonic Acid C-28-Triphenylphosphonium Conjugates with Variable Alkyl Linker Length. Antiangiogenic Effect of Isomalyngamide A ...
- Ultrasound Contrast Media (Contrast Agents) Market Size in 2023: Competitive landscape and Leading Country Data
The latest report on the global "Ultrasound Contrast Media (Contrast Agents) Market" provides valuable insights into the most recent trends in the industry. It conducts a thorough analysis within ...
- Phebra, University of Wollongong partner to develop cancer therapies
Dillon and Dr Judith Carrall invented the patent for the anti-cancer agent, which was published in 2019. Utilising a targeting system, the new molecule will deliver lower quantities of the active ...
Go deeper with Bing News on:
Ultrasound cancer treatment
- Newly 30 and with no prior health problems, she never imagined cancer.
The year 2022 was off to a good start for Lexie Scheucraft — until Mother's Day weekend, when she experienced abdomen pain and severe bloating.
- Ultrasound May Help Early Breast Cancer Patients Avoid SLNB
Omitting axillary surgery completely in early breast cancer patients with a negative preoperative axillary ultrasound resulted in similar outcomes compared with sentinel lymph node biopsy (SLNB), and ...
- New technology allows patients to skip radiation and surgery when treating prostate cancer
The side effects from chemotherapy, radiation or surgery can be rough and even life changing, for cancer patients. But now there is another option for treating prostate cancer.
- Tiny bubbles could reveal immune cell secrets and improve treatments
Macrophages are cells vital to the immune system and could possibly inform cell-based therapies for a variety of medical conditions. However, realizing the full potential of macrophage therapies ...
- 150 Milestone: Robotic Procedure Changes Prostate Cancer Care
UCSF Health achieves 150 robotic focal HIFU procedures for prostate cancer, pioneering precision therapy with minimal side effects, prioritizing quality of life preservation.